Jaguar Health, Inc.
JAGX
$10.91
-$0.83-7.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.18% | -26.69% | 21.88% | 24.39% | -20.96% |
| Total Depreciation and Amortization | 0.34% | -4.64% | -9.98% | 10.71% | -1.83% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -100.00% | -78.53% | -42.37% |
| Total Other Non-Cash Items | 7.06% | 374.14% | 49.81% | 137.77% | 3,084.78% |
| Change in Net Operating Assets | 56.76% | 96.82% | 37.91% | 14.53% | -43.51% |
| Cash from Operations | -5.03% | 6.61% | 9.78% | 29.14% | -16.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.97% | -- | -64.91% | 22.38% | 41.23% |
| Issuance of Common Stock | -69.94% | 163.75% | 333.90% | -29.97% | 276.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.55% | 10.00% | 53.47% | -103.49% | -- |
| Cash from Financing | -73.43% | 150.53% | 274.56% | -34.78% | 550.18% |
| Foreign Exchange rate Adjustments | -227.27% | 255.00% | 75.61% | -159.38% | -18.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -262.41% | 48.53% | 176.27% | -41.54% | 163.69% |